{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:12:00Z","timestamp":1791295920340,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"46-47","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.vaccine.2005.06.027","type":"journal-article","created":{"date-parts":[[2005,7,19]],"date-time":"2005-07-19T14:28:06Z","timestamp":1121783286000},"page":"5342-5350","source":"Crossref","is-referenced-by-count":18,"title":["Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis"],"prefix":"10.1016","volume":"23","author":[{"given":"F.","family":"M\u00e9gret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Prehaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lafage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Batejat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Escriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.I.","family":"Thoulouze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lafon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2005.06.027_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1568011033482404","article-title":"Death receptor signaling in cancer therapy","volume":"3","author":"Fulda","year":"2003","journal-title":"Curr Med Chem Anti-Cancer Agents"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2005.06.027_bib2","doi-asserted-by":"crossref","first-page":"14560","DOI":"10.1073\/pnas.0404758101","article-title":"Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections","volume":"101","author":"Hilleman","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2005.06.027_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nri11308","article-title":"Death-defying immunity: do apoptotic cells influence antigen processing and presentation?","volume":"4","author":"Albert","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.06.027_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1084\/jem.191.3.411","article-title":"The induction of tolerance by dendritic cells that have captured apoptotic cells","volume":"191","author":"Steinman","year":"2000","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2005.06.027_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.191.3.423","article-title":"Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells","volume":"191","author":"Sauter","year":"2000","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2005.06.027_bib6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20020263","article-title":"Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7","volume":"196","author":"Verbovetski","year":"2002","journal-title":"J Exp Med"},{"issue":"6671","key":"10.1016\/j.vaccine.2005.06.027_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2005.06.027_bib8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.188.7.1359","article-title":"Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes","volume":"188","author":"Albert","year":"1998","journal-title":"J Exp Med"},{"issue":"22","key":"10.1016\/j.vaccine.2005.06.027_bib9","first-page":"6441","article-title":"Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells","volume":"60","author":"Shaif-Muthana","year":"2000","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.vaccine.2005.06.027_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/10548","article-title":"Cancer therapy using a self-replicating RNA vaccine","volume":"5","author":"Ying","year":"1999","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.vaccine.2005.06.027_bib11","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/79470","article-title":"Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis","volume":"18","author":"Chattergoon","year":"2000","journal-title":"Nat Biotechnol"},{"issue":"22","key":"10.1016\/j.vaccine.2005.06.027_bib12","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1128\/JVI.75.22.10800-10807.2001","article-title":"Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity","volume":"75","author":"Pulmanausahakul","year":"2001","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.06.027_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/89289","article-title":"Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases","volume":"19","author":"Sasaki","year":"2001","journal-title":"Nat Biotechnol"},{"issue":"12","key":"10.1016\/j.vaccine.2005.06.027_bib14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/sj.gt.3301696","article-title":"Immunomodulation by apoptosis-inducing caspases for an influenza DNA vaccine delivered by gene gun","volume":"9","author":"Sasaki","year":"2002","journal-title":"Gene Ther"},{"issue":"17","key":"10.1016\/j.vaccine.2005.06.027_bib15","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2165\/00003495-200363170-00001","article-title":"The place of accelerated schedules for hepatitis A and B vaccinations","volume":"63","author":"Zuckerman","year":"2003","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.vaccine.2005.06.027_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1566524033479843","article-title":"Cytokine, chemokine, and costimulatory molecule modulation to enhance efficacy of HIV vaccines","volume":"3","author":"Ahlers","year":"2003","journal-title":"Curr Mol Med"},{"issue":"3","key":"10.1016\/j.vaccine.2005.06.027_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1566524033479825","article-title":"HIV vaccines: a global perspective","volume":"3","author":"Esparza","year":"2003","journal-title":"Curr Mol Med"},{"issue":"10","key":"10.1016\/j.vaccine.2005.06.027_bib18","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1128\/JVI.71.10.7372-7380.1997","article-title":"Rabies virus infects mouse and human lymphocytes and induces apoptosis","volume":"71","author":"Thoulouze","year":"1997","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.06.027_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0042-6822(03)00491-4","article-title":"High level of Bcl-2 counteracts apoptosis mediated by a live rabies virus vaccine strain and induces long-term infection","volume":"314","author":"Thoulouze","year":"2003","journal-title":"Virology"},{"issue":"19","key":"10.1016\/j.vaccine.2005.06.027_bib20","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1128\/JVI.77.19.10537-10547.2003","article-title":"Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis","volume":"77","author":"Prehaud","year":"2003","journal-title":"J Virol"},{"issue":"December","key":"10.1016\/j.vaccine.2005.06.027_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1196\/annals.1299.108","article-title":"Glycoprotein of non-pathogenic rabies viruses is a major inducer of apoptosis in human jurkat T cells","volume":"1010","author":"Lay","year":"2003","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2005.06.027_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/bjc.1950.36","article-title":"Studies in antibody response of mice to tumour inoculation","volume":"4","author":"Gorer","year":"1950","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2005.06.027_bib23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nbt0986-790","article-title":"AIDS virus ENV protein expressed from a recombinant vaccinia virus","volume":"4","author":"Kieny","year":"1986","journal-title":"Bio-Technology"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2005.06.027_bib24","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1099\/0022-1317-76-8-1999","article-title":"Cytotoxic T cell response to Mengo virus in mice: effector cell phenotype and target proteins","volume":"76","author":"Escriou","year":"1995","journal-title":"J Gen Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2005.06.027_bib25","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/0264-410X(93)90052-Y","article-title":"Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice","volume":"11","author":"Montano-Hirose","year":"1993","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2005.06.027_bib26","first-page":"1945","article-title":"Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays","volume":"53","author":"Gorczyca","year":"1993","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.vaccine.2005.06.027_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/088282402760312340","article-title":"Ultraviolet-irradiated vaccinia virus recombinants, exposing HIV-envelope on their outer membrane, induce antibodies against this antigen in rabbits","volume":"15","author":"Loewinger","year":"2002","journal-title":"Viral Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2005.06.027_bib28","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood.V94.4.1372","article-title":"Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus","volume":"94","author":"Subklewe","year":"1999","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.vaccine.2005.06.027_bib29","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1172\/JCI200114122","article-title":"Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences","volume":"108","author":"Fadok","year":"2001","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.vaccine.2005.06.027_bib30","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.4049\/jimmunol.173.5.2985","article-title":"Phosphatidylserine regulates the maturation of human dendritic cells","volume":"173","author":"Chen","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.06.027_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4049\/jimmunol.169.1.159","article-title":"Blebs and apoptotic bodies are B cell autoantigens","volume":"169","author":"Cocca","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.06.027_bib32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.16.3.754-759.1977","article-title":"Rabies virus glycoprotein. II. Biological and serological characterization","volume":"16","author":"Cox","year":"1977","journal-title":"Infect Immun"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2005.06.027_bib33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0147-9571(03)00019-5","article-title":"Poxviruses as vaccine vectors","volume":"26","author":"Pastoret","year":"2003","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2005.06.027_bib34","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1038\/sj.onc.1207517","article-title":"Role of AIF in caspase-dependent and caspase-independent cell death","volume":"23","author":"Cregan","year":"2004","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.vaccine.2005.06.027_bib35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ni0403-308","article-title":"Caspase activation is not death","volume":"4","author":"Perfettini","year":"2003","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.06.027_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1006\/mthe.2000.0071","article-title":"An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer","volume":"1","author":"Arafat","year":"2000","journal-title":"Mol Ther"},{"issue":"13","key":"10.1016\/j.vaccine.2005.06.027_bib37","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.1074\/jbc.273.13.7770","article-title":"The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition","volume":"273","author":"Pastorino","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2005.06.027_bib38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1091\/mbc.8.2.325","article-title":"Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe","volume":"8","author":"Jurgensmeier","year":"1997","journal-title":"Mol Biol Cell"},{"issue":"8","key":"10.1016\/j.vaccine.2005.06.027_bib39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/35085094","article-title":"The phosphatidylserine receptor: a crucial molecular switch?","volume":"2","author":"Henson","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6805","key":"10.1016\/j.vaccine.2005.06.027_bib40","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/35037722","article-title":"Corpse clearance defines the meaning of cell death","volume":"407","author":"Savill","year":"2000","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2005.06.027_bib41","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI200114002","article-title":"The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses","volume":"108","author":"Schmidt","year":"2001","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.vaccine.2005.06.027_bib42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri749","article-title":"Roles of heat-shock proteins in innate and adaptive immunity","volume":"2","author":"Srivastava","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2005.06.027_bib43","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.4049\/jimmunol.167.9.4844","article-title":"Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells","volume":"167","author":"Somersan","year":"2001","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.06.027_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1517\/14712598.2.3.249","article-title":"Cell-based therapy approaches using dying cells: from tumour immunotherapy to transplantation tolerance induction","volume":"2","author":"Saas","year":"2002","journal-title":"Expert Opin Biol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05006432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05006432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T08:16:55Z","timestamp":1586333815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05006432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":44,"journal-issue":{"issue":"46-47","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0264410X05006432"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.06.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}